Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey

Soysal A., Gokce I., Pehlivan T., Bakir M.

EUROPEAN JOURNAL OF PEDIATRICS, cilt.166, sa.6, ss.533-539, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 166 Sayı: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1007/s00431-007-0432-0
  • Dergi Adı: EUROPEAN JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.533-539
  • Anahtar Kelimeler: hepatitis A vaccine, children, seroprevalence, safety, immunogenicity, interchangeability, UNIVERSAL IMMUNIZATION, VIRUS-INFECTION, IMMUNOGENICITY, SAFETY, PREVALENCE, ANTIBODIES, SEROPREVALENCE, FORMULATION, PREVENTION, ASSAYS
  • Marmara Üniversitesi Adresli: Hayır

Özet

Introduction This randomised, observer-blind clinical trial conducted in Turkey evaluated the immunogenicity, safety and interchangeability of three paediatric inactivated hepatitis A vaccines in 424 seronegative children between 1 and 15 years of age.